MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    How reliable are non-blinded evaluations of motor UPDRS? a comparison of blinded vs. un-blinded UPDRS scores in 14 patients with advanced Parkinson´s disease

    G-M. Hariz, A. Fredricks, R. Stenmark, J. Linder, M. Hariz, L. Forsgren, P. Blomstedt (Umea, Sweden)

    Objective: To investigate the reliability of scores of the motor part of the Unified Parkinson Disease Rating Scale (UPDRS III) rated by an un-blinded specialist…
  • 2019 International Congress

    Effects of deep brain stimulation of the subthalamic nucleus on the postoperative levodopa response: one year follow up

    E. Kocabicak, O. Yildiz, D. Aygun, Y. Temel (Maastricht, Netherlands)

    Objective: In this study, we planned to research the effect of preoperative levodopa response to postoperative levodopa response and clinical outcome. Background: Deep brain stimulation…
  • 2019 International Congress

    Combined STN and NBM DBS in PD and mild to moderate Parkinson’s dementia

    R. Nickl, P. Fricke, P. Capetian, M. Reich, J. Krapp, V. Sturm, J. Volkmann, C. Matthies (Wuerzburg, Germany)

    Objective: While deep brain stimulation (DBS) of the subthalamic nucleus (STN) alleviates Parkinson"s Disease(PD) related motor symptoms, to date PD dementia (PDD) patients are excluded…
  • 2019 International Congress

    Deep Brain Stimulation for Parkinson’s disease: the Paradox of More Technological Approaches

    D. Soh, T. Ten Brinke, A. Lozano, A. Fasano (Toronto, ON, Canada)

    Objective: To assess the subjective experience/expectations of Parkinson’s disease(PD) patients who have undergone deep brain stimulation(DBS) using either an established(Medtronic, Minneapolis, MN, USA) or newer…
  • 2019 International Congress

    Global implementation of efficacious voice treatment for Parkinson’s disease: LSVT LOUD in Germany, France and Japan

    L. Ramig, T. Brauer, C. Airiau, M. Fujiu-Kurachi (Boulder, CO, USA)

    Objective: This study was designed to evaluate the implementation of an efficacious voice treatment, Lee Silverman Voice Treatment (LSVT LOUD), into scope of clinical practice…
  • 2019 International Congress

    A Large-Scale Survey of Rock Steady Boxing (RSB) Utilization in Parkinson’s Disease

    D. Bega, D. Larson, M. Rafferty (Chicago, IL, USA)

    Objective: To better understand the demographic profile of PD patients who attend RSB, to define motivators and barriers to participation, and to assess the perceived…
  • 2019 International Congress

    Implementation of a Peer-to-Peer Mentoring Intervention for Center of Excellence Coordinators

    C. Hunter, K. Arney, J. Fleisher, P. Palmentera, J. Shurer, F. Cubillos (Houston, TX, USA)

    Objective: Through the Centers of Excellence (COE) network, the Parkinson’s Foundation (PF) unites a community dedicated to improving clinical care in Parkinson’s disease (PD). Each…
  • 2019 International Congress

    Management of life threatening dyskinesias in GNAO1 related movement disorder: two new cases and review of the literature

    M. Hull, M. Parnes (Houston, TX, USA)

    Objective: To present two cases of GNAO1 related movement disorder associated with life threatening persistent chorea successfully managed with bilateral GPi deep brain stimulation (GPi-DBS)…
  • 2019 International Congress

    Association between coffee and chimarrão (yerba mate) ingestion and risk of Parkinson’s disease

    MS. Medeiros, AF. Schumacher-Schuh, V. Altmann, CRM. Rieder (Porto Alegre, Brazil)

    Objective: To assess whether the ingestion loads (quantity x time) of coffee, and specially yerba mate in southern Brazil, reduce the risk of PD. Background:…
  • 2019 International Congress

    Health associated quality of life (HAQL) and humor/cognitive complaints predict mortality in Parkinson’s disease (PD)

    P. Bugalho, R. Barbosa, F. Ladeira, J. Marto, C. Borbinha, L. Conceição, M. Saraiva, M. Salavisa, B. Meira, M. Fernandes (Lisbon, Portugal)

    Objective: To assess the value of motor (MS), non-motor symptoms (NMS), HAQL and activities of daily living (ADL) for predicting mortality in PD. Background: Parkinson’s…
  • « Previous Page
  • 1
  • …
  • 24
  • 25
  • 26
  • 27
  • 28
  • …
  • 217
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley